Z. Xu, “Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway”, Cell Mol Biol (Noisy-le-grand), vol. 66, no. 5, pp. 199–203, Jul. 2020.